here debug-> :lcxx11708

Life ScienceInvesting News

Your trusted source for investing success

Life Science

Do you like the idea of getting in early on life science companies that could be the next Medtronic or Pharmacyte?

Get an edge with our FREE Special Report, Life Science Investing Primer – Finding More Opportunities like Medtronic, Ariad Pharmaceuticals and Pharmacyte.

Dear Life Science Investor,

Almost 10% of global GDP is spent on keeping people healthy.

Except in the US where, in 2013, 17% of the total economic output of the country was spent on healthcare. That’s over $2.8 trillion!

As the world’s reliance on pharmaceutical drugs increases investing in life sciences companies is a solid investment strategy.

Investing in companies like Pfizer, Medtronic or Johnson & Johnson are a good part of an investment strategy, but what about the companies you don’t hear about until they make the national news? Companies like Ariad Pharmaceuticals and Pharmacyte that have provided investors with bigger investment gains?

Start with this FREE Special Report: Life Science Investing Primer – Finding More Opportunities like Medtronic, Ariad Pharmaceuticals and PharmacyteDownload it now!

This FREE Special Report, Life Science Investing Primer – Finding More Opportunities like Medtronic, Ariad Pharmaceuticals and Pharmacyte, is designed to help you …

  • Educate yourself on what is happening with the Life Science market and the companies in it
  • Consider the different markets within life sciences and which you think will do best
  • Understand what stages life science companies go through and when there is the biggest risk – and the biggest reward
  • Evaluate the experts’ opinions and forecasts for yourself before making any investments
  • Gain expertise in life science investing
  • Confidently make buying and selling decisions all year long, whenever you see an opportunity
  • Profit from what the world needs while helping companies build their success

There is a lot of information in the news about healthcare and life sciences companies. But how much about investing in those companies? There is some, but that information usually focuses on the big names – names the investors already know about.

There are thousands of life sciences companies that represent different types of investment opportunities. We have provided you with a great place to start.

Why you should read Life Science Investing Primer – Finding More Opportunities like Medtronic, Ariad Pharmaceuticals and Pharmacyte

Life Science Investing News is part of Investing News Network, a growing network of authoritative publications delivering independent, unbiased news and education for investors. We deliver knowledgeable, carefully curated coverage of a variety of markets including life science, resource, technology and many others. This means you read nothing but the best from the entire world of investing advice, and never have to waste your valuable time doing hours, days or weeks of research yourself.

At the same time, not a single word of the content we choose for you is paid for by Pfizer or Medtronic or any company or investment advisor: We choose our content based solely on its informational and educational value to you, the investor.

Of course, investing in life science companies isn’t for everyone. When you read this free report, you’ll learn one of the cardinal rules: Have patience. You’ll learn to distinguish between the pessimists who only consider short-term investing and those experts who take the long view – a view that could turn out to be very profitable indeed.

I’m sure you can see the value of such investing intelligence. And we have carefully selected unbiased, independent articles to put into this FREE Special Report, Life Science Investing Primer – Finding More Opportunities like Medtronic, Ariad Pharmaceuticals and Pharmacyte.

We created this special report because there is so much to know about investing in life science companies such as Medtronic that we wanted to make it easy for you to get started. And as for why we would give away such valuable advice, the answer is simple: It’s the best way we know to introduce ourselves and get this information into the hands of as many investors as possible.

So if you want to invest in a way that takes advantage of one of the most powerful mega-trends our generation — or any generation — will ever see…

If you believe your hard earned investment dollars should go to companies that are dedicated to improving the lives of others…

If you want to learn how to evaluate life science companies before they are in the headlines…

Start today with this free special report. Right now.

After all, a lot of people know that investing in healthcare has significant upside potential. Aging populations in the most wealthy countries will be spending trillions on their health and trying to maintain a healthy lifestyle. If you’re the kind of person who likes to identify new products and trends to improve your investing results — to find the companies to invest in before everyone else — then you shouldn’t wait to start reading this Special Report.

The range of different types of healthcare companies to invest in is vast. Are you looking for companies that are trying to cure Alzheimers? Or companies that help those with diabetes test their blood sugar? What about companies that make “superfoods” that will help you live longer and healthier?

This Special Report is a great place to start. Life Science Investing Primer – Finding More Opportunities like Medtronic, Ariad Pharmaceuticals and Pharmacyte touches on all of these topics and more. And if you’re interested in what the experts are looking at, try the article covering JPMorgan’s or Motley Fool’s 2015 life science stock picks. Both great places to start!

As with many other markets, there are also ETF’s or Exchange Traded Funds in the healthcare market. First and foremost, ETFs are designed to allow investors exposure to specific market sectors at a relatively low cost. ETFs are often less costly than active mutual funds while still giving investors the chance to access hundreds or even thousands of stocks like Medtronic.

Changing demographics of the US are contributing to the popularity of healthcare ETFs. Baby boomers, those born between the years 1946 and 1964, represent approximately one-quarter of the US population, according to the Population Reference Bureau. More importantly, as this generation continues to age, it will result in much more spending in the healthcare sector, from prescription drugs to hospital care.

This is not the kind of opportunity that comes twice. Don’t wait to start reading this Special Report.

What you will learn when you read Life Science Investing Primer – Finding More Opportunities like Medtronic, Ariad Pharmaceuticals and Pharmacyte

What if you don’t want to invest directly in companies like Medtronic and Pfizer?

This free Special Report covers all the bases for investors interested in life sciences. If you don’t want to invest in companies directly, you might want to chose to invest in an ETF, an exchange-traded fund covering many life science stocks.

A recent report from Barron’s maintains that since the beginning of 2014, healthcare has outpaced every other sector in the S&P 500, not to mention the broader stock market as a whole. The healthcare sector has been seeing major gains since 2010. In fact, a 2013 report from CNBC and Yahoo Finance showed that if you used the SPDR Health Care ETF as a measure, which includes Johnson & Johnson and Medtronic, healthcare companies have experienced gains of nearly 64 percent since March 23, 2010, eclipsing the 52 percent rise posted by the S&P 500.

In all, there simply is no other single resource that brings together the best current information on life science investing, whether you’re a novice healthcare investor or an old hand. This free Special Report, Life Science Investing Primer, is, if you’ll pardon the pun, just what the doctor ordered! Download it today!

And at this price – $0.00 – it’s certainly affordable! Don’t waste another minute wondering how what company is going to be the next Ariad Pharmaceuticals and Pharmacyte, or in trying to sift through the onslaught of information – some of it valuable, much of it not – on your own. Read our Special Report today, and start making savvy investing decisions tomorrow!

We’re pleased to be able to make it available to you at no cost, and hope you’ll take advantage of the expertise it delivers.

Yours for profitable, healthy investing,

Nick Smith
Publisher & CEO
Investing News Network

PS: Did I mention that this Special Report also includes numerous links to additional insight – information you might never find on your own? This is the kind of guidance that’s a deal at any price — but especially when it’s FREE. Download it today!

PPS: Here at Life Science Investing Network, we have no hidden, vested interest in getting you to invest in life science companies. This report was not sponsored by Medtronic. We simply believe investors like you deserve the best professional guidance available, and we just happen to deliver it for free in this Special Report. Read it now!

*Your free Life Science Investor Kits include:

  • Naturally Splendid Enterprises
  • DelMar Pharmaceuticals
  • BioSig Technologies
  • Q BioMed
  • Laguna Blends
  • RespireRx Pharmaceuticals
  • Eyecarrot Innovations
  • 3D Signatures
  • Luminor Medical Technologies

Leave a Reply

Enter Your Log In Credentials

Privacy & Legal Policy

Privacy Policy

Investing News Network